Biotech Market

Biotech Market Share & Analysis – Industry Overview

Base Year: 2024 Historical Data: 2021-23
  • Report ID: TBI-14769
  • Published Date: Jun, 2025
  • Pages: 238
  • Category: Healthcare
  • Format: PDF
Buy @ $4700.00 Request Sample PDF

Segment Analysis

Regional segmentation analysis

The regions analyzed for the market include North America, Europe, South America, Asia Pacific, the Middle East, and Africa. North America emerged as the most significant global biotech market, with a 40% market revenue share in 2024.

North America’s position as a leader comes from placing a strong focus on research and development (R&D), assisted by many renowned universities, research institutes and centres for biotechnology in the region. The cluster brings together academics, industry groups and government which furthers the biotech innovations and growth. Biotech innovation is promoted and new drugs are approved more quickly, thanks to large government funding from the NIH and flexible policies set by the FDA. Besides, North America is supported by a well-developed healthcare setting, quite a high budget for healthcare and nationwide use of advanced tech in medicine, all of which increase the demand for biopharmaceuticals and precision medicines. The large number of leading biopharmaceutical companies, new startups and contract research organizations (CROs) make the market lively and attract much venture capital funding. In addition, having good intellectual property protection laws in the area helps companies increase innovation by making their investments more secure. AI and bioinformatics are being widely used in drug discovery and personalized healthcare in North America which is why the region is leading in digital biotech adoption. Also, due to more chronic diseases, people living longer and knowing more about modern biotech approaches, the market keeps growing steadily.

North America Region Biotech Market Share in 2024 - 40%

 

www.thebrainyinsights.com

Check the geographical analysis of this market by requesting a free sample

  • With a licensing agreement worth up to $870 million, Eli Lilly is relying on Camurus and its long-acting delivery technology to help advance its line of diabetes and obesity medications. Through the collaboration, Lilly will be able to create and market long-acting incretin medicines based on up to four of its own compounds using Camurus' FluidCrystal technology.  Camurus is eligible to receive upfront, development, and regulatory milestone payments totalling up to $290 million in exchange.  Along with tiered mid-single-digit royalties on worldwide net product sales, the Swedish company is also entitled for an additional $580 million in sales-based milestone payments.

Application Segment Analysis

The application segment is divided into healthcare/medical biotechnology, agricultural biotechnology, industrial biotechnology, environmental biotechnology, animal biotechnology and marine biotechnology. The healthcare/medical biotechnology segment dominated the market, with a market share of around 36% in 2024. Healthcare or medical biotechnology represents the biggest share in the global biotechnology market because of its key role in supporting human health and new advances in medicine. More people suffering from chronic problems like cancer, diabetes and heart conditions are a major reason why personalized and effective treatments are now more necessary. Biologics have become very important in oncology, autoimmune diseases and rare genetic disorders, so this sector is now a leading source of revenue for biotech companies. The COVID-19 pandemic emphasized the significance of healthcare biotechnology, as biotechnology firms quickly introduced mRNA vaccines and diagnostic kits, proving the field can quickly help when there are global health threats. People looking for treatments specific to their genetics have increased the demand for biotech ideas in diagnostics and therapeutic solutions. Greater funding, relaxed regulations and new AI and data analytics technology have allowed this segment to lead the biotech industry for a long time. Besides, as populations around the globe age, demand for regenerative medicine and chronic disease care has gone up, giving healthcare biotech more reasons to succeed.

  • In order to bring innovative biosurfactants to the North American personal care industry, Belgian biotech company AmphiStar has established a strategic alliance with Kensing, a US-based manufacturer of speciality surfactants and plant-based chemicals. Through the cooperation, Kensing's industrial capabilities and market access will be combined with AmphiStar's IP-backed biosurfactant platform, which is made exclusively from agri-food waste.  By offering a sustainable, circular substitute, the companies want to upend the traditional surfactant supply chain.  AmphiStar's biosurfactants, which are made from microbial fermentation and biobased waste streams, are expected to have a substantially smaller environmental impact than first-generation biosurfactants made from palm oil or other crops as well as petrochemical-based biosurfactants.

Technology Segment Analysis

The technology segment is divided into DNA sequencing and recombinant technology, cell and tissue culture, fermentation, PCR technology, chromatography, nanobiotechnology, CRISPR and gene editing and bioinformatics. The DNA sequencing and recombinant technology segment dominated the market, with a market share of around 33% in 2024. DNA sequencing and recombinant DNA technology lead the global biotechnology sector because they form the core of present-day biological studies, diagnostics and creating new drugs. DNA sequencing enables the understanding of precise arrangement of DNA letters which helps in the discovery of genes involved in diseases and offer personalized medical care. Now with NGS, sequencing is more accurate, time-efficient and cheaper, so it has been more widely adopted by healthcare, farming, police investigation and microbiology. Recombinant DNA technology generally means combining pieces of DNA from various sources to make something new. Making genetically engineered organisms, therapeutic proteins, insulin, growth hormones and monoclonal antibodies requires this type of technology. It helps to advance the progress of drugs and genetic engineering in health care and agriculture. Manipulating genes now makes it possible for scientists to design new vaccines, gene therapies and synthetic biology techniques that improve public health and farming. They also lead in their field because they are used widely in science, healthcare and business and keep advancing with new technology. Finding drugs, creating vaccines and providing diagnostics often depends on these technologies by major biotech and pharmaceutical companies.

  • A Memorandum of Understanding (MoU) has been signed between Klinikum rechts der Isar, the university hospital connected to the Technical University of Munich (TUM), Germany, and MarkHerz Inc., a biotechnology startup based in South Korea that specialises in AAV-based gene therapies targeting cardiovascular and metabolic diseases.  The goal of the agreement is to create a wide-ranging partnership for the collaborative study and development of next-generation gene treatments for peripheral vascular and ischaemic heart disorders.  The focus of this will be on MarkHerz's exclusive MAAV Platform, which makes it possible to create pinpointed AAV (adeno associated virus) gene treatments, especially its MRTF-A candidate.  Preclinical and clinical studies, technology consultation, and research infrastructure sharing are all part of the partnership.

End-User Segment Analysis

The end-user segment is divided into biopharmaceutical companies, academic & research institutes, CROs (contract research organizations), biotechnology companies, hospitals & clinics and agriculture & food industry. The biopharmaceutical companies segment dominated the market, with a market share of around 38% in 2024. They concentrate on creating biologics which include monoclonal antibodies, recombinant proteins, gene therapies and vaccines. The rise in chronic diseases, rare genetic disorders and cancer has placed biopharmaceuticals at the forefront of more effective and targeted treatments. The powerful position of big pharma depends on their abundant investments in research and development (R&D), strategic partnerships with universities and new biotech firms and strong infrastructure for clinical trials and meeting regulations. Biopharma firms use their resources and infrastructure to bring difficult and long-term studies from research to commercialization. They are major users and supporters of advanced technologies such as CRISPR, cell and gene therapy and AI in medicine which adds to their overall leadership in the sector. COVID-19 showed that these companies were critical, as leaders in the field rapidly brought out vaccines and treatments with mRNA technology. On a global scale, their supply chains provided them with the ability to mass-manufacture and rapidly send products to people. In addition, these companies are protected by strong patents, regulations and high costs for newcomers to the industry which explains their stability and profitability.

  • In order to co-sell SCIEX mass spectrometry systems with the recently announced Evosep Eno for standardised high-throughput proteomics, Evosep Biosystems, a global leader in proteomics solutions, and SCIEX, a global leader in life science analytical technologies and operating company of Danaher Corporation have entered into a reseller agreement.  Through a new reseller partnership, SCIEX and Evosep increase Pharma and Biotech's access to standardised proteomics.  The reseller agreement gives researchers the ability to use standardised proteomics processes, providing a reliable LC-MS solution made to satisfy the changing needs of biotech and pharmaceutical businesses.  Researchers may achieve remarkable throughput, sensitivity, and reproducibility with Evosep Eno.  This partnership guarantees access to state-of-the-art technology designed to meet today's analytical challenges when paired with SCIEX mass spectrometers, which are designed for speed and sensitivity in both quantitative and qualitative analysis.

Request Table of Content

+1

This study forecasts revenue at global, regional, and country levels from 2021 to 2034. The Brainy Insights has segmented the global biotech market based on below mentioned segments:

Global Biotech Market by Application:

  • Healthcare / Medical Biotechnology
  • Agricultural Biotechnology
  • Industrial Biotechnology
  • Environmental Biotechnology
  • Animal Biotechnology
  • Marine Biotechnology

Global Biotech Market by Technology:

  • DNA Sequencing and Recombinant Technology
  • Cell and Tissue Culture
  • Fermentation
  • PCR Technology
  • Chromatography
  • Nanobiotechnology
  • CRISPR and Gene Editing
  • Bioinformatics

Global Biotech Market by End-User:

  • Biopharmaceutical Companies
  • Academic & Research Institutes
  • CROs (Contract Research Organizations)
  • Biotechnology Companies
  • Hospitals & Clinics
  • Agriculture & Food Industry

Global Biotech Market by Region:

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
  • Asia-Pacific
    • Japan
    • China
    • India
  • South America
    • Brazil
  • Middle East and Africa  
    • UAE
    • South Africa

Methodology

Research has its special purpose to undertake marketing efficiently. In this competitive scenario, businesses need information across all industry verticals; the information about customer wants, market demand, competition, industry trends, distribution channels etc. This information needs to be updated regularly because businesses operate in a dynamic environment. Our organization, The Brainy Insights incorporates scientific and systematic research procedures in order to get proper market insights and industry analysis for overall business success. The analysis consists of studying the market from a miniscule level wherein we implement statistical tools which helps us in examining the data with accuracy and precision. 

Our research reports feature both; quantitative and qualitative aspects for any market. Qualitative information for any market research process are fundamental because they reveal the customer needs and wants, usage and consumption for any product/service related to a specific industry. This in turn aids the marketers/investors in knowing certain perceptions of the customers. Qualitative research can enlighten about the different product concepts and designs along with unique service offering that in turn, helps define marketing problems and generate opportunities. On the other hand, quantitative research engages with the data collection process through interviews, e-mail interactions, surveys and pilot studies. Quantitative aspects for the market research are useful to validate the hypotheses generated during qualitative research method, explore empirical patterns in the data with the help of statistical tools, and finally make the market estimations.

The Brainy Insights offers comprehensive research and analysis, based on a wide assortment of factual insights gained through interviews with CXOs and global experts and secondary data from reliable sources. Our analysts and industry specialist assume vital roles in building up statistical tools and analysis models, which are used to analyse the data and arrive at accurate insights with exceedingly informative research discoveries. The data provided by our organization have proven precious to a diverse range of companies, facilitating them to address issues such as determining which products/services are the most appealing, whether or not customers use the product in the manner anticipated, the purchasing intentions of the market and many others.

Our research methodology encompasses an idyllic combination of primary and secondary initiatives. Key phases involved in this process are listed below:

MARKET RESEARCH PROCESS

Data Procurement:

The phase involves the gathering and collecting of market data and its related information with the help of different sources & research procedures.

The data procurement stage involves in data gathering and collecting through various data sources.

This stage involves in extensive research. These data sources includes:

Purchased Database: Purchased databases play a crucial role in estimating the market sizes irrespective of the domain. Our purchased database includes:

  • The organizational databases such as D&B Hoovers, and Bloomberg that helps us to identify the competitive scenario of the key market players/organizations along with the financial information.
  • Industry/Market databases such as Statista, and Factiva provides market/industry insights and deduce certain formulations. 
  • We also have contractual agreements with various reputed data providers and third party vendors who provide information which are not limited to:
    • Import & Export Data
    • Business Trade Information
    • Usage rates of a particular product/service on certain demographics mainly focusing on the unmet prerequisites

Primary Research: The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. Primary research mainly involves in telephonic interviews, E-mail interactions and face-to-face interviews with the raw material providers, manufacturers/producers, distributors, & independent consultants. The interviews that we conduct provides valuable data on market size and industry growth trends prevailing in the market. Our organization also conducts surveys with the various industry experts in order to gain overall insights of the industry/market. For instance, in healthcare industry we conduct surveys with the pharmacists, doctors, surgeons and nurses in order to gain insights and key information of a medical product/device/equipment which the customers are going to usage. Surveys are conducted in the form of questionnaire designed by our own analyst team. Surveys plays an important role in primary research because surveys helps us to identify the key target audiences of the market. Additionally, surveys helps to identify the key target audience engaged with the market. Our survey team conducts the survey by targeting the key audience, thus gaining insights from them. Based on the perspectives of the customers, this information is utilized to formulate market strategies. Moreover, market surveys helps us to understand the current competitive situation of the industry. To be precise, our survey process typically involve with the 360 analysis of the market. This analytical process begins by identifying the prospective customers for a product or service related to the market/industry to obtain data on how a product/service could fit into customers’ lives.

Secondary Research: The secondary data sources includes information published by the on-profit organizations such as World bank, WHO, company fillings, investor presentations, annual reports, national government documents, statistical databases, blogs, articles, white papers and others. From the annual report, we analyse a company’s revenue to understand the key segment and market share of that organization in a particular region. We analyse the company websites and adopt the product mapping technique which is important for deriving the segment revenue. In the product mapping method, we select and categorize the products offered by the companies catering to domain specific market, deduce the product revenue for each of the companies so as to get overall estimation of the market size. We also source data and analyses trends based on information received from supply side and demand side intermediaries in the value chain. The supply side denotes the data gathered from supplier, distributor, wholesaler and the demand side illustrates the data gathered from the end customers for respective market domain.

The supply side for a domain specific market is analysed by:

  • Estimating and projecting penetration rates through analysing product attributes, availability of internal and external substitutes, followed by pricing analysis of the product.
  • Experiential assessment of year-on-year sales of the product by conducting interviews.

The demand side for the market is estimated through:

  • Evaluating the penetration level and usage rates of the product.
  • Referring to the historical data to determine the growth rate and evaluate the industry trends

In-house Library: Apart from these third-party sources, we have our in-house library of qualitative and quantitative information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, historic databases, internal audit reports and archives.

Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those cases, we use our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopt a robust research technique in order to produce the estimates:

  • Applying demographic along with psychographic segmentation for market evaluation
  • Determining the Micro and Macro-economic indicators for each region 
  • Examining the industry indicators prevailing in the market. 

Data Synthesis: This stage involves the analysis & mapping of all the information obtained from the previous step. It also involves in scrutinizing the data for any discrepancy observed while data gathering related to the market. The data is collected with consideration to the heterogeneity of sources. Robust scientific techniques are in place for synthesizing disparate data sets and provide the essential contextual information that can orient market strategies. The Brainy Insights has extensive experience in data synthesis where the data passes through various stages:

  • Data Screening: Data screening is the process of scrutinising data/information collected from primary research for errors and amending those collected data before data integration method. The screening involves in examining raw data, identifying errors and dealing with missing data. The purpose of the data screening is to ensure data is correctly entered or not. The Brainy Insights employs objective and systematic data screening grades involving repeated cycles of quality checks, screening and suspect analysis.
  • Data Integration: Integrating multiple data streams is necessary to produce research studies that provide in-depth picture to the clients. These data streams come from multiple research studies and our in house database. After screening of the data, our analysts conduct creative integration of data sets, optimizing connections between integrated surveys and syndicated data sources. There are mainly 2 research approaches that we follow in order to integrate our data; top down approach and bottom up approach.

Market Deduction & Formulation: The final stage comprises of assigning data points at appropriate market spaces so as to deduce feasible conclusions. Analyst perspective & subject matter expert based holistic form of market sizing coupled with industry analysis also plays a crucial role in this stage.

This stage involves in finalization of the market size and numbers that we have collected from data integration step. With data interpolation, it is made sure that there is no gap in the market data. Successful trend analysis is done by our analysts using extrapolation techniques, which provide the best possible forecasts for the market.

Data Validation & Market Feedback: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helps us finalize data-points to be used for final calculations.

The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. The data validation interview and discussion panels are typically composed of the most experienced industry members. The participants include, however, are not limited to:

  • CXOs and VPs of leading companies’ specific to sector
  • Purchasing managers, technical personnel, end-users
  • Key opinion leaders such as investment bankers, and industry consultants

Moreover, we always validate our data and findings through primary respondents from all the major regions we are working on.

Some Facts About The Brainy Insights

50%

Free Customization

300+

Fortune 500 Clients

1

Free Yearly Update On Purchase Of Multi/Corporate License

900+

Companies Served Till Date